333 related articles for article (PubMed ID: 18182685)
21. Model-based calculation of thyroid gland normal tissue complication probability in head and neck cancer patients after radiation therapy.
Kinclová I; Hajtmanová E; Matula P; Balentová S; Muríň P; Ďuroška M; Kozlíková K
Strahlenther Onkol; 2020 Jun; 196(6):561-568. PubMed ID: 32016495
[TBL] [Abstract][Full Text] [Related]
22. Combining the LKB NTCP model with radiosensitivity parameters to characterize toxicity of radionuclides based on a multiclonogen kidney model: a theoretical assessment.
Lin H; Jing J; Xu L; Wu D; Xu Y
Australas Phys Eng Sci Med; 2012 Jun; 35(2):165-76. PubMed ID: 22678954
[TBL] [Abstract][Full Text] [Related]
23. Inclusion of biological factors in parallel-architecture normal-tissue complication probability model for radiation-induced liver disease.
Cheng JC; Liu HS; Wu JK; Chung HW; Jan GJ
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1150-6. PubMed ID: 15990021
[TBL] [Abstract][Full Text] [Related]
24. A free program for calculating EUD-based NTCP and TCP in external beam radiotherapy.
Gay HA; Niemierko A
Phys Med; 2007 Dec; 23(3-4):115-25. PubMed ID: 17825595
[TBL] [Abstract][Full Text] [Related]
25. Normal tissue complication probability modelling of tissue fibrosis following breast radiotherapy.
Alexander MA; Brooks WA; Blake SW
Phys Med Biol; 2007 Apr; 52(7):1831-43. PubMed ID: 17374914
[TBL] [Abstract][Full Text] [Related]
26. Optimization of equivalent uniform dose using the L-curve criterion.
Chvetsov AV; Dempsey JF; Palta JR
Phys Med Biol; 2007 Oct; 52(19):5973-84. PubMed ID: 17881813
[TBL] [Abstract][Full Text] [Related]
27. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
Tucker SL; Liu HH; Wang S; Wei X; Liao Z; Komaki R; Cox JD; Mohan R
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):754-61. PubMed ID: 16965865
[TBL] [Abstract][Full Text] [Related]
28. CalcNTCP: a simple tool for computation of normal tissue complication probability (NTCP) associated with cancer radiotherapy.
Khan HA
Int J Radiat Biol; 2007 Oct; 83(10):717-20. PubMed ID: 17729166
[TBL] [Abstract][Full Text] [Related]
29. Comparison of non-coplanar and coplanar irradiation techniques to treat cancer of the pancreas.
Osborne C; Bydder SA; Ebert MA; Spry NA
Australas Radiol; 2006 Oct; 50(5):463-7. PubMed ID: 16981944
[TBL] [Abstract][Full Text] [Related]
30. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
[TBL] [Abstract][Full Text] [Related]
31. RADBIOMOD: A simple program for utilising biological modelling in radiotherapy plan evaluation.
Chang JH; Gehrke C; Prabhakar R; Gill S; Wada M; Lim Joon D; Khoo V
Phys Med; 2016 Jan; 32(1):248-54. PubMed ID: 26549777
[TBL] [Abstract][Full Text] [Related]
32. A general tumour control probability model for non-uniform dose distributions.
González SJ; Carando DG
Math Med Biol; 2008 Jun; 25(2):171-84. PubMed ID: 18515259
[TBL] [Abstract][Full Text] [Related]
33. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
[TBL] [Abstract][Full Text] [Related]
34. A free software for the evaluation and comparison of dose response models in clinical radiotherapy (DORES).
Tsougos I; Grout I; Theodorou K; Kappas C
Int J Radiat Biol; 2009 Mar; 85(3):227-37. PubMed ID: 19296336
[TBL] [Abstract][Full Text] [Related]
35. EUD-based biological optimization for carbon ion therapy.
Brüningk SC; Kamp F; Wilkens JJ
Med Phys; 2015 Nov; 42(11):6248-57. PubMed ID: 26520717
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric parameters in partial breast irradiation through brachytherapy.
Gloi A; McCourt S; Buchanan R; Goetller A; Zuge C; Balzoa P; Cooley G
Med Dosim; 2009; 34(3):207-13. PubMed ID: 19647630
[TBL] [Abstract][Full Text] [Related]
37. Predicting radiation pneumonitis in lung cancer: a EUD-based machine learning approach for volumetric modulated arc therapy patients.
Ye F; Xu L; Ren Y; Xia B; Chen X; Ma S; Deng Q; Li X
Front Oncol; 2024; 14():1343170. PubMed ID: 38357195
[TBL] [Abstract][Full Text] [Related]
38. Equivalent uniform dose concept evaluated by theoretical dose volume histograms for thoracic irradiation.
Dumas JL; Lorchel F; Perrot Y; Aletti P; Noel A; Wolf D; Courvoisier P; Bosset JF
Phys Med; 2007 Mar; 23(1):16-24. PubMed ID: 17568539
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of an indigenous, radiobiological model-based tumor control probability and normal tissue complication probability estimation software for routine plan evaluation in clinics.
Patel G; Mandal A; Bharati A; Choudhary S; Mishra R; Mourya A
J Cancer Res Ther; 2022; 18(6):1697-1705. PubMed ID: 36412432
[TBL] [Abstract][Full Text] [Related]
40. Effect of Cisplatin on parotid gland function in concomitant radiochemotherapy.
Hey J; Setz J; Gerlach R; Vordermark D; Gernhardt CR; Kuhnt T
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1475-80. PubMed ID: 19515505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
